RMTG (Regenerative Medical Technology Group) FCF Margin % : 22.21% (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Regenerative Medical Technology Group's Free Cash Flow for the three months ended in Sep. 2024 was $0.22 Mil. Regenerative Medical Technology Group's Revenue for the three months ended in Sep. 2024 was $0.99 Mil. Therefore, Regenerative Medical Technology Group's FCF Margin % for the quarter that ended in Sep. 2024 was 22.21%.

As of today, Regenerative Medical Technology Group's current FCF Yield % is -2.00%.

The historical rank and industry rank for Regenerative Medical Technology Group's FCF Margin % or its related term are showing as below:

RMTG' s FCF Margin % Range Over the Past 10 Years
Min: -2255.48 Med: -498 Max: -0.25
Current: -0.25

During the past 7 years, the highest FCF Margin % of Regenerative Medical Technology Group was -0.25%. The lowest was -2255.48%. And the median was -498.00%.

RMTG's FCF Margin % is ranked better than
77.38% of 1008 companies
in the Biotechnology industry
Industry Median: -127.825 vs RMTG: -0.25

Regenerative Medical Technology Group FCF Margin % Historical Data

The historical data trend for Regenerative Medical Technology Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerative Medical Technology Group FCF Margin % Chart

Regenerative Medical Technology Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,206.67

-587.27

-2,255.48

-85.75

-33.40

Regenerative Medical Technology Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-12.52	-50.81	6.00	4.67	22.21

Competitive Comparison of Regenerative Medical Technology Group's FCF Margin %

For the Biotechnology subindustry, Regenerative Medical Technology Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Regenerative Medical Technology Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Regenerative Medical Technology Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.805	/	2.41
	=	-33.40 %

Regenerative Medical Technology Group's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	0.219	/	0.986
	=	22.21 %

Regenerative Medical Technology Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerative Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432

Website

https://www.regenmedtechgroup.com

Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.

Executives

Benito Novas	10 percent owner	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen	director, 10 percent owner, officer: President and CEO	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria	director, 10 percent owner, officer: CEO, Chairman	RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803